12:00 AM
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Deals

Sulfagenix, Nuevas Alternativas Naturales Thermafat, S.A. de C.V. deal

Sulfagenix acquired an exclusive license to U.S. Patent No. 8,361,514 covering the composition of sulfur molecules used to treat oxidative stress from Nuevas Alternativas. Sulfagenix said the patent...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >